chr2-31533741-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBP7
The NM_000348.4(SRD5A2):c.307C>A(p.Arg103Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000617 in 1,603,408 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00030 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000037 ( 0 hom. )
Consequence
SRD5A2
NM_000348.4 synonymous
NM_000348.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.77
Publications
5 publications found
Genes affected
SRD5A2 (HGNC:11285): (steroid 5 alpha-reductase 2) This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH). [provided by RefSeq, Jul 2008]
SRD5A2 Gene-Disease associations (from GenCC):
- 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 2-31533741-G-T is Benign according to our data. Variant chr2-31533741-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 2709890.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=2.77 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SRD5A2 | NM_000348.4 | c.307C>A | p.Arg103Arg | synonymous_variant | Exon 2 of 5 | ENST00000622030.2 | NP_000339.2 | |
| SRD5A2 | XM_011533069.3 | c.85C>A | p.Arg29Arg | synonymous_variant | Exon 2 of 5 | XP_011531371.1 | ||
| SRD5A2 | XM_011533072.3 | c.52C>A | p.Arg18Arg | synonymous_variant | Exon 4 of 7 | XP_011531374.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152178Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
46
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000946 AC: 22AN: 232538 AF XY: 0.0000240 show subpopulations
GnomAD2 exomes
AF:
AC:
22
AN:
232538
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000372 AC: 54AN: 1451114Hom.: 0 Cov.: 30 AF XY: 0.0000375 AC XY: 27AN XY: 720284 show subpopulations
GnomAD4 exome
AF:
AC:
54
AN:
1451114
Hom.:
Cov.:
30
AF XY:
AC XY:
27
AN XY:
720284
show subpopulations
African (AFR)
AF:
AC:
41
AN:
33346
American (AMR)
AF:
AC:
1
AN:
43486
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25894
East Asian (EAS)
AF:
AC:
0
AN:
39338
South Asian (SAS)
AF:
AC:
0
AN:
83368
European-Finnish (FIN)
AF:
AC:
0
AN:
52898
Middle Eastern (MID)
AF:
AC:
1
AN:
5712
European-Non Finnish (NFE)
AF:
AC:
5
AN:
1106968
Other (OTH)
AF:
AC:
6
AN:
60104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000295 AC: 45AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74472 show subpopulations
GnomAD4 genome
AF:
AC:
45
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74472
show subpopulations
African (AFR)
AF:
AC:
43
AN:
41568
American (AMR)
AF:
AC:
0
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5180
South Asian (SAS)
AF:
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68024
Other (OTH)
AF:
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency Benign:1
Jan 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.